Immunohistochemical examination of cholecystokinin and gastrin receptors (CCK-2/gastrin-R) expression in normal and exocrine cancerous human pancreatic tissues

被引:2
|
作者
Sellam, Feriel [1 ]
Harir, Noria [1 ]
Khaled, Meghit B. [1 ]
Mrabent, Nesrine M. [1 ]
Belkralladi, Houria [2 ]
Tou, Abdelnacer [2 ]
Diaf, Mustapha [1 ]
Salah, Rachida [1 ]
Moulessehoul, Soraya [1 ]
机构
[1] Djillali Liabes Univ Sidi Bel Abbes, Dept Biol, Sidi Bel Abbes, Algeria
[2] Hassani Abdelkader Univ Hosp, Dept Pathol, Sidi Bel Abbes, Algeria
关键词
Pancreatic cancer; CCK-2/gastrin-R; Expression; Immunohistochemistry; G protein couped receptors; Cholecystokinin; RISK-FACTORS; MEDICAL CONDITIONS; DIABETES-MELLITUS; CCK2; RECEPTORS; MESSENGER-RNA; CHOLECYSTECTOMY; GROWTH; GALLSTONES; COHORT; PROLIFERATION;
D O I
10.1016/j.pan.2015.09.019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Evaluating tissue samples of normal and exocrine cancerous human pancreas on the expression of CCK2/gastrin receptor. We performed an immunohistochemical protocol that allows efficient detection of this receptor in formalin-fixed, paraffin-embedded human tissues. Methods: Twenty (20) paraffin blocks of pancreatic tissue sections were collected from the Departments of pathology, Central University Hospital of Sidi-bel-Abbes City (Western Algeria) for the period 2004 2013; ten (10) of them were normal pancreatic samples; and ten (10) cancerous pancreatic sections. The samples were studied using an immunohistochemical protocol for CCK-2/gastrin receptors. Results: Our immunohistochemical analysis revealed that CCK-2/gastrin receptors were expressed in both normal and malignant pancreatic cells but with different immunoreactivity levels and different immunostaining intensity i.e., CCK-2/gastrin receptors were highly expressed within the cytoplasmic area of cancerous cells; 40% of the samples had an immunoreactivity (IR) of (+++) and 60% (++++); the immunostaining was as well very intense since we reported a dark brown staining of the malignant cells. However; in normal pancreatic tissues; CCK-2/gastrin receptors IR levels were very low; 80% of the samples had an IR of (+); and 20% had (++) and the immunostaining was less intense; we noted a light brown staining of few normal pancreatic cells. Conclusion: The gastrointestinal peptides CCK could be very interesting targets for exocrine pancreatic cancer therapies; thus further surveys such as western blotting and RTPCR could indentify CCK-2/gastrin receptors as a helpful biomarker for exocrine pancreatic cancer diagnosis and treatment. Copyright (C) 2015, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.
引用
收藏
页码:661 / 666
页数:6
相关论文
共 16 条
  • [1] Immunohistochemical Examination of Gastrin, Gastrin Precursors, and Gastrin/CCK-2 Receptor in Human Esophageal Squamous Cell Carcinomas
    Yuan, Aping
    Liu, Jinzhong
    Liu, Yiqing
    Bjornsen, Tone
    Varro, Andrea
    Cui, Guanglin
    PATHOLOGY & ONCOLOGY RESEARCH, 2008, 14 (04) : 449 - 455
  • [2] CHARACTERIZATION OF CHOLECYSTOKININ RECEPTORS (CCK-R) IN NORMAL AND CANCEROUS HUMAN-PANCREAS
    SINGH, P
    TOWNSEND, CM
    UPP, J
    LARIDJANI, A
    THOMPSON, JC
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 291 - 291
  • [3] Cholecystokinin, gastrin, cholecystokinin/gastrin receptors, and bitter taste receptor TAS2R14: trophoblast expression and signaling
    Taher, Shedy
    Borja, Yamilette
    Cabanela, Lucia
    Costers, Vincent J.
    Carson-Marino, Morgan
    Bailes, Julie C.
    Dhar, Biswadeep
    Beckworth, Mark T.
    Rabaglino, Maria B.
    Uiterweer, Emiel D. Post
    Conrad, Kirk P.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2019, 316 (05) : R628 - R639
  • [4] Immunohistochemical localization of CCK1 cholecystokinin receptors in normal and neoplastic human tissues
    Schulz, S
    Röcken, C
    Mawrin, C
    Schulz, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11): : 6149 - 6155
  • [5] INTERNALIZATION OF CHOLECYSTOKININ (CCK)-GASTRIN RECEPTORS BY THE PANCREATIC-CELL LINE AR-4-2J
    SVOBODA, M
    TASTENOY, M
    BUI, D
    LAMBERT, M
    CHRISTOPHE, J
    NEUROPEPTIDE CHOLECYSTOKININ ( CCK ): ANATOMY AND BIOCHEMISTRY, RECEPTORS, PHARMACOLOGY AND PHYSIOLOGY, 1989, : 199 - 204
  • [6] Induction of gastrin/cholecystokinin receptor (CCK2R) expression in response to cellular stress in vitro and in vivo
    Ashurst, Louise
    Varro, Andrea
    Dimaline, Rod
    GASTROENTEROLOGY, 2007, 132 (04) : A224 - A224
  • [7] CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells
    Kato, Hiroki
    Seto, Koichi
    Kobayashi, Nobuyoshi
    Yoshinaga, Koji
    Meyer, Tim
    Takei, Mineo
    LIFE SCIENCES, 2011, 89 (17-18) : 603 - 608
  • [8] Cholecystokinin, gastrin, cholecystokinin/gastrin receptors, and bitter taste receptor, TAS2R14: trophoblast expression and signaling (vol 316, pg R628, 2019)
    Taher, S.
    Borja, Y.
    Cabanela, L.
    Costers, V. J.
    Carson-Marino, M.
    Bailes, J. C.
    Dhar, B.
    Beckworth, M. T.
    Rabaglino, M. B.
    Uiterweer, Post E. D.
    Conrad, K. P.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2019, 317 (02) : R355 - R355
  • [9] Helicobacter pylori may up-regulate gastrin/CCK-2 receptor expression in exposed cells and human gastric mucosa
    Dickson, JH
    Atherton, J
    Watson, SA
    Watson, SA
    GASTROENTEROLOGY, 2005, 128 (04) : A593 - A594
  • [10] Inhibitory effect of Z-360, a novel, orally active CCK-2/Gastrin receptor antagonist, on gastrin-17-induced proliferation, Pkb/Akt phosphorylation and in vivo growth of human pancreatic adenocarcinoma cell lines
    Emori, Yutaka
    Kawasaki, Daisuke
    Eta, Runa
    Iino, Yuka
    Hamano, Hiroki
    Yoshmaga, Koji
    Tanaka, Takao
    Takei, Mineo
    Watsori, Susan A.
    GASTROENTEROLOGY, 2007, 132 (04) : A433 - A434